| For: | Takai E, Yachida S. Genomic alterations in pancreatic cancer and their relevance to therapy. World J Gastrointest Oncol 2015; 7(10): 250-258 [PMID: 26483879 DOI: 10.4251/wjgo.v7.i10.250] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i10/250.htm |
| Number | Citing Articles |
| 1 |
Cheng Xiong, Youwei Zhu, Meilin Xue, Yongsheng Jiang, Yiming Zhong, Lingxi Jiang, Minmin Shi, Hao Chen. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition. Aging 2021; 13(3) doi: 10.18632/aging.202264
|
| 2 |
Qingyun Zhu, Xinting Pan, Yunbo Sun, Zhengbin Wang, Fuguo Liu, Aiqin Li, Zhihui Zhao, Yunlong Wang, Kun Li, Liangyu Mi, Jose G. Trevino. Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo. PLOS ONE 2017; 12(10) doi: 10.1371/journal.pone.0185507
|
| 3 |
Robin Imperial, Omer M Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications. Seminars in Cancer Biology 2019; 54 doi: 10.1016/j.semcancer.2017.11.016
|
| 4 |
Claudio Luchini, Paola Capelli, Aldo Scarpa. Pancreatic Ductal Adenocarcinoma and Its Variants. Surgical Pathology Clinics 2016; 9(4) doi: 10.1016/j.path.2016.05.003
|
| 5 |
Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences 2017; 18(6) doi: 10.3390/ijms18061201
|
| 6 |
Enza Vernucci, Jaime Abrego, Venugopal Gunda, Surendra K. Shukla, Aneesha Dasgupta, Vikrant Rai, Nina Chaika, Kyla Buettner, Alysha Illies, Fang Yu, Audrey J. Lazenby, Benjamin J. Swanson, Pankaj K. Singh. Metabolic Alterations in Pancreatic Cancer Progression. Cancers 2019; 12(1) doi: 10.3390/cancers12010002
|
| 7 |
Michele Masetti, Giorgia Acquaviva, Michela Visani, Giovanni Tallini, Adele Fornelli, Moira Ragazzi, Francesco Vasuri, Daniela Grifoni, Simone Di Giacomo, Sirio Fiorino, Raffaele Lombardi, David Tuminati, Matteo Ravaioli, Carlo Fabbri, Maria Letizia Bacchi-Reggiani, Annalisa Pession, Elio Jovine, Dario de Biase. Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer Biomarkers 2018; 21(2) doi: 10.3233/CBM-170464
|
| 8 |
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolism. Critical Reviews in Oncology/Hematology 2017; 114 doi: 10.1016/j.critrevonc.2017.03.026
|
| 9 |
Robert Matera, Muhammad Wasif Saif. New therapeutic directions for advanced pancreatic cancer: cell cycle inhibitors, stromal modifiers and conjugated therapies. Expert Opinion on Emerging Drugs 2017; 22(3) doi: 10.1080/14728214.2017.1362388
|
| 10 |
Jana Tarabay, Xiaodong Li, Vishal S. Chandan. Adenosquamous carcinoma of the pancreas. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6) doi: 10.1016/j.clinre.2020.01.008
|
| 11 |
Sara Calistri, Giuseppe Ottaviano, Alberto Ubaldini. Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions. Pharmaceuticals 2024; 17(10) doi: 10.3390/ph17101314
|
| 12 |
Soon-Chan Kim, Young-Kyoung Shin, Sun-Whe Kim, Ha-Young Seo, Wooil Kwon, Hongbeom Kim, Youngmin Han, Ja-Oh Lee, Jin-Young Jang, Ja-Lok Ku. Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line. Pancreas 2019; 48(10) doi: 10.1097/MPA.0000000000001420
|
| 13 |
Robert Słotwiński, Gustaw Lech, Sylwia Małgorzata Słotwińska. Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets. Central European Journal of Immunology 2021; 46(2) doi: 10.5114/ceji.2021.107027
|
| 14 |
Marwa Alhothali, Mevin Mathew, Geeta Iyer, Harshani R. Lawrence, Shengyu Yang, Srikumar Chellappan, Jaya Padmanabhan. Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC. International Journal of Molecular Sciences 2019; 20(10) doi: 10.3390/ijms20102423
|
| 15 |
Matteo Giulietti, Giulia Occhipinti, Giovanni Principato, Francesco Piva. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development. Cellular Oncology 2016; 39(4) doi: 10.1007/s13402-016-0283-7
|
| 16 |
Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith, Rajesh Agarwal. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors. Molecular Carcinogenesis 2020; 59(10) doi: 10.1002/mc.23251
|
| 17 |
Çiğdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Murat Serilmez, Faruk Tas. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Journal of Infection and Chemotherapy 2017; 23(4) doi: 10.1016/j.jiac.2016.12.003
|
| 18 |
Şeyda Kaya, Mustafa Murat Öztürk, Dilek Arslan Ateşşahin, İnanç Baral, Sevgi Durna Daştan. Molecular Perspective on Pancreatic Cancers with a Focus on Genetics, Genomics, and Diagnostics. Cumhuriyet Science Journal 2026; 47(3) doi: 10.17776/csj.1854954
|
| 19 |
Angelyn V. Nguyen, Brittany Trompetto, Xing Haw Marvin Tan, Michael B. Scott, Kenneth Hsueh-heng Hu, Eric Deeds, Manish J. Butte, Pei Yu Chiou, Amy C. Rowat. Differential Contributions of Actin and Myosin to the Physical Phenotypes and Invasion of Pancreatic Cancer Cells. Cellular and Molecular Bioengineering 2020; 13(1) doi: 10.1007/s12195-019-00603-1
|
| 20 |
Soumaya Menadi, Burak Kucuk, Ercan Cacan. Promoter Hypomethylation Upregulates ANXA2 Expression in Pancreatic Cancer and is Associated with Poor Prognosis. Biochemical Genetics 2024; 62(4) doi: 10.1007/s10528-023-10577-5
|